A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke

Clinical trial NCT07318714 · RECRUITING

Trial details

NCT number: NCT07318714
Sponsor: Astellas Pharma Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Ischemic Stroke

Start date: 2026-04-03
Primary completion: 2030-02-28
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.